Topical azathioprine in the treatment of immune-mediated chronic oral inflammatory conditions: A series of cases

Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics

Volumn 91, Issue 1, 2001, Pages 56-61

  Epstein, Joel B ^a,b,d   Gorsky, M ^c   Epstein, M S ^a   Nantel, S ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF WASHINGTON   (United States)

^c TEL AVIV UNIVERSITY   (Israel)

^d BRITISH COLUMBIA CANCER AGENCY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; IMMUNOSUPPRESSIVE AGENT;

ADULT; ARTICLE; AUTOIMMUNE DISEASE; CHRONIC DISEASE; ERYTHEMA; FEMALE; GEL; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNOLOGY; MALE; MIDDLE AGED; MOUTH HYGIENE; MOUTH ULCER; MUCOUS MEMBRANE PEMPHIGOID; PEMPHIGUS; STOMATITIS;

ADULT; AUTOIMMUNE DISEASES; AZATHIOPRINE; CHRONIC DISEASE; ERYTHEMA; FEMALE; GELS; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; MOUTHWASHES; ORAL ULCER; PEMPHIGOID, BENIGN MUCOUS MEMBRANE; PEMPHIGUS; STOMATITIS;

EID: 0035228888     PISSN: 10792104     EISSN: None     Source Type: Journal    
DOI: 10.1067/moe.2001.111130     Document Type: Article

References (30)

1. Woo SB, Lee SJ, Schubert MM. Graft-vs-host disease. Crit Rev Oral Biol Med 1997;8:201-16.
2. Schwinghammer TL, Bloom EJ. Pharmacologic prophylaxis of acute graft-versus-host disease after allogeneic marrow transplantation. Clin Pharm 1993;12:736-61.
3. Schubert MM, Sullivan KM. Recognition, incidence, and management of oral graft-versus-host disease. NCI Monogr 1990;9:135-43.
4. Nakamura S, Hiroki A, Shinohara M, Gondo H, Ohyama Y, Mouri T, et al. Oral involvement in chronic graft-versus-host disease after allogeneic bone marrow transplantation. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1996;82:556-63.
5. Robinson JR, Lozada-Nur F, Frieden I. Oral pemphigus vulgaris. A review of the literature and a report on the management of 12 cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1997;84:349-55.
6. Silverman S Jr, Gorsky M, Lozada-Nur F, Liu A. Oral mucous membrane pemphigoid. A study of 65 patients. Oral Surg Oral Med Oral Pathol 1986;61:233-7.
7. Lozada F. Prednisone and azathioprine in the treatment of patients with vesiculoerosive oral diseases. Oral Surg Oral Med Oral Pathol 1981;52:257-60.
8. Epstein JB, Reece DE. Topical cyclosporin A for treatment of oral chronic graft-versus-host disease. Bone Marrow Transplant 1994;13:81-6.
9. Epstein JB, Truelove EL. Topical cyclosporin in a bioadhesive for treatment of oral lichenoid mucosal reactions. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1996;82:532-6.
10. Gooptu C, Staughton RC. Use of topical cyclosporin in oral pemphigus. J Acad Dermatol 1998;38:860-1.
11. Greinix HT, Volc-Platzer B, Rabitsch W, Gmeinhart B, Guevara-Pineda C, Kalhs P, et al. Successful use of extracorporeal photochemotherapy in the treatment of severe acute and chronic graft-versus-host disease. Blood 1998;92:3098-104.
12. Redding SW, Callander NS, Haveman CW, Leonard DL. Treatment of oral chronic graft-versus-host disease with PUVA therapy: case report and literature review. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1998;86:183-7.
13. Vogelsang GB, Wolff D, Altomonte V, Farmer E, Morison WL, Corio R. Treatment of chronic graft-versus-host disease with ultraviolet irradiation and psoralen (PUVA). Bone Marrow Transplant 1996;17:1061-7.
14. Eggleston DJ, Nally FF. Treatment of aphthous ulceration with topical azathioprine. A double blind trial. Br J Oral Surg 1972;9:233-6.
15. Suchko VI, Mashchenko IS. Local use of an azathioprine suspension in a dimexide solution in the combined treatment of periodontosis. Stomologica (Mosk) 1981;60:28-30.
16. Epstein JB, Nantel S, Sheoltch M. Topical azathioprine in the combined treatment of chronic oral graft-versus-host disease: a case report. Bone Marrow Transplant 2000;25:683-7.
17. Zins BJ, Sandborn WJ, McKinney JA, Mays DC, van Os EC, Tremaine WJ, et al. A dose-ranging study of azathioprine pharmacokinetics after single-dose administration of a delayed-release oral formulation. J Clin Pharmacol 1997;37:38-46.
18. Van Os EC, Zins BJ, Sandborn WJ, Mays DC, Tremaine WJ, Mahoney DW, et al. Azathioprine pharmacokinetics after intravenous, oral, delayed release oral and rectal foam administration. Gut 1996;39:63-8.
19. Sandborn WJ. A review of immune modifier therapy for inflammatory bowel disease: azathioprine, 6-mercaptourine, cyclosporine, and methotrexate. Am J Gastroenterol 1996;91:423-33.
20. Winklestein A. The effects of azathioprine and 6-MP on immunity. J Immunopharmacol 1979; 1:429-54.
21. Brogan M, Hiserodt J, Oliver M, Stevens R, Korelitz B, Targan S. The effect of 6-mercaptopurine on natural killer-cell activities in Crohn's disease. J Clin Immunol 1985;5:204-11.
22. Brogan M, Stevens R, Hiserodt J, et al. Effects of 6-MP on the impaired in vivo humoral responsiveness in Crohn's disease. Gastroenterol 1984;86:A1035.
23. Lear JT, English JSC. Erosive and generalized lichen planus responsive to azathioprine. Clin Exper Derm 1996;21:56-7.
24. Sandborn WJ. A review of immune modifier therapy for inflammatory bowel disease: azathioprine, 6-mercaptourine, cyclosporine, and methotrexate. Am J Gastroenterol 1996;91:423-33.
25. Allen LV Jr, Erickson MA 3rd. Stability of acetazolamide, allopurinol, azathioprine, clonazepam, and flucytosine in extemporaneously compounded oral liquids. Am J Health Syst Pharm 1996;53:1944-9.
26. Elliot JH, Leibowitz HM. Chemotherapeutic immunosuppression of the corneal graft reaction. Part 3. Topical azathioprine. Arch Opthalmol 1966;76:709-11.
27. Mackay IR, Bignell JL, Smith PH, Crawford BA. Prevention of corneal-graft failure with the immunosuppressive drug azathioprine. Lancet 1967;514:479-82.
28. Griffin MG, Miner PB Jr. Conventional drug therapy in inflammatory bowel disease. Gastroenterol Clin North Am 1995;24:509-21.
29. Choi PM, Targan SR. Immunomodulator Therapy in Inflammatory Bowel Disease. Dig Dis Sci 1994;39:1885-92.
30. Stotland BR, Lichtenstein GR. Newer treatments for inflammatory bowel disease. Prim Care 1996;3:577-608.